✨ Medicine Distribution Consents
1158 NEW ZEALAND GAZETTE No. 45
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Hydrocortisone 5 mg, 20 mg | Tablets | Douglas Pharmaceuticals Limited, Mount Roskill, Auckland | — |
| Pantoprazole 40 mg | Tablet | Byk Gulden Lombergh Chemische Fabrik GmbH., Konstanze, Germany | Somac |
| Dacarbazine 200 mg | Powder for injection | David Bull Laboratories Limited, Mulgrave North, Victoria, Australia | Dacarbazine for Injection |
| Cefoxitin sodium 1 g, 2 g | Powder for injection | ACS Dobfar SpA, Tribiano, Milan, Italy | Cefoxitin Sodium for Injection |
Dated this 3rd day of May 1995.
DAVID SMYTH, Acting Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.
go3011
Consent to the Distribution of a New Related Product
Pursuant to section 96 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Stannous fluoride 0.40% w/v | Toothpaste | Chemplex Liquid, Division of CCL Industries, Etobicoke, Ontario, Canada | Oral-B Tooth and Gum Care |
Dated this 3rd day of May 1995.
DAVID SMYTH, Acting Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.
go3012
Consent to the Distribution of Changed Medicines
Pursuant to section 24 (5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Nedocromil sodium 2% w/v in 2.5 mL, 5 mL, and 10 mL | Ophthalmic drops | Fisons Laboratories SA, Le Trait, France and Fisons plc., Holmes Chapel, Crewe, Cheshire, England | Tilavist Eye Drops |
| Nafarelin acetate equivalent to 2 mg/mL nafarelin base in 10 mL | Nasal spray (metered dose) | Syntex Laboratories, Leuville-sur-Orge, Montlhéry, France and Syntex Laboratories Inc., Palo Alto, California, United States of America | Synarel |
| Clarithromycin 250 mg, 500 mg | Tablet | Abbott Australasia Pty Limited, Kurnell, New South Wales, Australia and Abbott Laboratories Limited, Queensborough, Kent, England and Abbott SpA, Latina, Italy | Klacid |
| Clarithromycin 125 mg/5 mL, 250 mg/5 mL | Granules for oral suspension | Abbott Australasia Pty Limited, Kurnell, New South Wales, Australia and Abbott Laboratories Limited, Queensborough, Kent, England and Abbott SpA, Latina, Italy | Klacid Paediatric Suspension |
| Felodipine 2.5 mg, 5 mg, 10 mg | Tablets, sustained release | Astra Pharmaceutical Production AB, Södertälje, Sweden | Agon SR |
| Heparin sodium (tinzaparin sodium) 10 000 anti-Xa IU/mL in 2 mL | Injection (multi-dose vials) | Novo Nordisk A/S, Bagsvaerd, Copenhagen, Denmark | Logiparin 10 000 anti-Xa IU |
| Heparin sodium (tinzaparin sodium) 20 000 anti-Xa IU/mL in 5 mL | Injection (multi-dose vials) | Novo Nordisk A/S, Gentofte, Denmark | Logiparin 20 000 anti-Xa IU/mL |
| Heparin sodium (tinzaparin sodium) 20 000 anti-Xa IU/mL in 1 mL | Injection (vial) | Novo Nordisk A/S, Gentofte, Denmark | Logiparin 20 000 anti-Xa IU/mL |
| Omeprazole 20 mg | Capsule | Astra Pharmaceutical Production AB, Södertälje, Sweden | Losec |
| Omeprazole 42.6 mg (equivalent to 40 mg omeprazole) in 10 mL | Powder for IV injection (ampoule) plus diluent | Astra Pharmaceutical Production AB, Södertälje, Sweden | Losec |
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1995, No 45
NZLII —
NZ Gazette 1995, No 45
✨ LLM interpretation of page content
🏥 Consent to Distribution of New Medicines
🏥 Health & Social Welfare3 May 1995
Medicine Approval, New Medicines, Medicines Act 1981
- DAVID SMYTH, Acting Director-General of Health
🏥 Consent to the Distribution of a New Related Product
🏥 Health & Social Welfare3 May 1995
Medicine Approval, New Related Product, Medicines Act 1981
- DAVID SMYTH, Acting Director-General of Health
🏥 Consent to the Distribution of Changed Medicines
🏥 Health & Social Welfare3 May 1995
Medicine Approval, Changed Medicines, Medicines Act 1981
- DAVID SMYTH, Acting Director-General of Health